Translation and Validation of the MQOL Self-questionnaire Into French for Assessing Quality of Life in Patients With Meningiomas

Meningiomas, which account for about 40% of primary central nervous system tumors, have significant psychological and social impacts, even without treatment. Their effect on quality of life is often underestimated and poorly documented. There is one validated questionnaire (MQOL) but it has not yet been translated into French. The project involves two phases: first, translating and linguistically validating the MQOL into French; second, scientifically validating the questionnaire with 50 meningioma patients using established scales (EQ-5D, Karnofsky, FACT-Br) to ensure its reliability and internal consistency.

NCT Number	NCT07044076
Lead Sponsor	Centre Hospitalier St Anne
Conditions	Quality of Life, Meningioma
Enrollment	50 participants
Start Date	2025-06-13
Primary Completion	2025-07-13 (estimated)
Study Completion	2025-12-12 (estimated)
Updated on ClinicalTrials.gov	2025-06-29